KELIX BIO Trademark

Trademark Overview


On Thursday, September 2, 2021, a trademark application was filed for KELIX BIO with the United States Patent and Trademark Office. The USPTO has given the KELIX BIO trademark a serial number of 79325175. The federal status of this trademark filing is REGISTERED as of Tuesday, April 11, 2023. This trademark is owned by Kelix Bio Limited. The KELIX BIO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceuticals and natural remedies, namely, pharmaceutical preparations for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; medical preparations for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; injectable pharmaceuticals for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological,...

Medical apparatus and instruments for treating infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; medical instruments for treating infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; inhalers for therapeutic use; medical inhalers, namely, inhalers for medical use; physical therapy equipment in the nature of foam rollers, manually-operated resistance tubing, weighted balls
kelix bio

General Information


Serial Number79325175
Word MarkKELIX BIO
Filing DateThursday, September 2, 2021
Status700 - REGISTERED
Status DateTuesday, April 11, 2023
Registration Number7021135
Registration DateTuesday, April 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesPharmaceuticals and natural remedies, namely, pharmaceutical preparations for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; medical preparations for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; injectable pharmaceuticals for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; injectable dermal fillers; biological preparations for medical purposes, namely, pharmaceutical preparations for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; pharmaceutical preparations for inhalers for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; vitamins; medicinal preparations for the treatment of infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; diagnostic preparations and materials, namely, diagnostic agents, preparations and substances for medical purposes; respiratory stimulants; compounds, namely, medicine for treating respiratory diseases; pharmaceutical products for treating respiratory diseases; dermatological pharmaceutical products
Goods and ServicesMedical apparatus and instruments for treating infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; medical instruments for treating infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, nephrological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, blood disorders, lymphatic system and immune system related diseases and disorders; inhalers for therapeutic use; medical inhalers, namely, inhalers for medical use; physical therapy equipment in the nature of foam rollers, manually-operated resistance tubing, weighted balls
Disclaimer with Predetermined Text"BIO"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, November 12, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKelix Bio Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameKelix Bio Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameKelix Bio Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, August 14, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, July 26, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 26, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 11, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 11, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 19, 2022EXAMINER'S AMENDMENT ENTERED
Monday, December 19, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 19, 2022EXAMINERS AMENDMENT E-MAILED
Monday, December 19, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, December 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 13, 2022REFUSAL PROCESSED BY IB
Thursday, June 16, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 16, 2022REFUSAL PROCESSED BY MPU
Tuesday, June 14, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 13, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 8, 2022ASSIGNED TO EXAMINER
Sunday, December 5, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 16, 2021APPLICATION FILING RECEIPT MAILED
Friday, November 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB